Faricimab-svoa (Intraocular)
Medically reviewed by Drugs.com. Last updated on Dec 17, 2022.
Commonly used brand name(s)
In the U.S.
- Vabysmo
Available Dosage Forms:
- Solution
Pharmacologic Class: Faricimab
Uses for faricimab-svoa
Faricimab-svoa injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurring of vision or blindness. Faricimab-svoa works by changing the amount of blood that gets to the eye.
Faricimab-svoa injection is also used in diabetic patients who have diabetic macular edema (DME). Macular edema can cause loss of vision.
Faricimab-svoa is to be given only by or under the direct supervision of your doctor.
Before using faricimab-svoa
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For faricimab-svoa, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to faricimab-svoa or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of faricimab-svoa injection in the pediatric population. Safety and efficacy have not been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of faricimab-svoa injection in the elderly.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Interactions with food/tobacco/alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other medical problems
The presence of other medical problems may affect the use of faricimab-svoa. Make sure you tell your doctor if you have any other medical problems, especially:
- Eye infection or
- Eye swelling, active—Should not be used in patients with these conditions.
Proper use of faricimab-svoa
An ophthalmologist (eye doctor) will give you faricimab-svoa as a shot into the eye. Faricimab-svoa is usually given every 4 weeks (about every 28 days) for at least 4 doses. Some patients may receive additional doses every 4 weeks after the first 4 injections.
Precautions while using faricimab-svoa
Your eye doctor will want to check your progress at regular visits, especially during the first few days after you receive faricimab-svoa, to make sure faricimab-svoa is working properly and to check for unwanted effects.
Receiving faricimab-svoa while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant during treatment and for at least 3 months after the last dose. If you think you have become pregnant while receiving faricimab-svoa, tell your doctor right away.
Serious eye or vision problems (eg, eye infection or retinal detachment) may occur with faricimab-svoa. Check with your eye doctor right away if your have blurred or other change in vision, eye pain, eye redness, headache, seeing flashes or sparks of light, seeing floating spots before the eyes, or a veil or curtain appearing across part of vision, or tearing of the eyes several days after you receive faricimab-svoa. Also, tell your eye doctor if you feel increased pressure in your eye.
Faricimab-svoa may increase your risk of blood clots, heart attack, or stroke. Check with your doctor right away if you are having pain in your chest, groin, or legs, especially the calves, difficulty or trouble breathing, a severe, sudden headache, slurred speech, sudden loss of coordination, sudden, severe weakness or numbness in your arm or leg, or vision changes.
Faricimab-svoa may cause temporary blurred vision. Do not drive or do anything else that could be dangerous until you can see clearly.
Faricimab-svoa side effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
More common
- Bloody eye
- redness of the eye
Less common
- Blurred vision
- change in vision
- eye pain
- loss of vision
- red, sore eyes
- seeing floaters, veil or curtain appearing across part of vision
- seeing floating dark spots or material before the eyes
- tearing
Rare
- Eye irritation
- seeing light flashes
- watering of the eyes
Incidence not known
- Chest pain, discomfort, or tightness
- fast heartbeat
- fever
- hives, itching, rash
- hoarseness
- irritation
- joint pain, stiffness, or swelling
- nausea
- pain or discomfort in the arms, jaw, back, or neck
- redness of the skin
- stroke
- sweating
- swelling of the eyelids, face, lips, hands, or feet
- trouble breathing
- vomiting
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
More about faricimab
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.